NCT03483545View on ClinicalTrials.gov

Menopur And Rekovelle Combination Study

NACompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

July 17, 2018

Primary Completion Date

July 31, 2019

Study Completion Date

July 31, 2019

Conditions
Fertility Disorders
Interventions
COMBINATION_PRODUCT

Follitropin delta and HP-hMG

Follitropin delta dose will be determined by AMG and weight in Kg. Highly purified human menopausal gonadotrophin will be determined by follitropin delta dose and body weight in Kg

Trial Locations (4)

V5Z 3X7

Olive Fertility Centre, Vancouver

M4W 3R2

Hannam Fertility Centre, Toronto

M5G 1N8

CReATe Fertility Centre, Toronto

H4P 2S4

Clinique Ovo, Montreal

All Listed Sponsors
collaborator

Create Fertility Center

OTHER

collaborator

Olive Fertility Centre

OTHER

collaborator

Hannam Fertility Centre

UNKNOWN

lead

Dr François Bissonnette

INDUSTRY

NCT03483545 - Menopur And Rekovelle Combination Study | Biotech Hunter | Biotech Hunter